Owners, management and financials
CVR: 39085127
DKK 6,977,057
Revenue
Net result: DKK 1,065,066
Kenneth Graabek Johansen (50-66,65%), Roald Forsberg (50-66,65%)
2 more
CVR · view owners
Kenneth Graabek Johansen, Roald Forsberg
CVR · view management
Active
Founded 9 November 2017
CVR · view overview
3 employees
CVR · 2018
Owner registered: KGJ Invest ApS
CVR · 31/12/2022
View the full event history
Raven biosciences ApS is a Danish company of the type Anpartsselskab based in Aarhus N, founded in 2017. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Kenneth Graabek Johansen and Roald Forsberg. The company's owners include Kenneth Graabek Johansen, Roald Forsberg and KGJ Invest ApS. The company has 3 employees (2018). In 2025, the company reported revenue of DKK 6,977,057 and a net result of DKK 1,065,066 compared with DKK -925,200 the year before. Equity in the 2025 report amounted to DKK 2,861,815.
Source: annual report 2025, Danish Business Authority
Raven biosciences ApS demonstrates a fluctuating financial trajectory, with a notable decline in revenue from 12.67 million DKK in 2022 to 6.98 million DKK in 2025, alongside a recovery from a loss of 925,200 DKK in 2024 to a profit of 1,065,066 DKK in 2025. The company's equity has shown a positive trend, increasing from 1.02 million DKK in 2021 to 2.86 million DKK in 2025, indicating improved financial stability. However, the significant drop in revenue over the past few years raises concerns about its market position and growth potential within the computer consulting and facility management industry. Overall, while profitability has returned, the company must address revenue volatility to strengthen its competitive standing.
AI-generated summary · Generated 01/07/2026
Selskabets formål er at udvikle software og yde konsulentassistance.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 7 mio. | 1.1 mio. | 5.4 mio. | 2.9 mio. | 9 | |
| 202401/01/2024 – 31/12/2024 | 5.1 mio. | -925 t. | 5.3 mio. | 1.8 mio. | 9 | |
| 202301/01/2023 – 31/12/2023 | 7.1 mio. | 430 t. | 7.3 mio. | 3.9 mio. | 7 | |
| 202201/01/2022 – 31/12/2022 | 12.7 mio. | 2.5 mio. | 7.9 mio. | 3.5 mio. | 4 | |
| 202101/01/2021 – 31/12/2021 | 6 mio. | 710 t. | 3 mio. | 1 mio. | - | |
| 202001/01/2020 – 31/12/2020 | 2.2 mio. | -255 t. | 975 t. | 413 t. | - | |
| 201901/01/2019 – 31/12/2019 | 4.8 mio. | 413 t. | 1.1 mio. | 669 t. | - |
Compared to 6.316 companies in Computerkonsulentbistand og forvaltning af computerfaciliteter
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreThe CVR number of Raven biosciences ApS is 39085127.
The owners of Raven biosciences ApS include Kenneth Graabek Johansen, Roald Forsberg and KGJ Invest ApS.
The management of Raven biosciences ApS consists of Kenneth Graabek Johansen and Roald Forsberg.
In 2025, Raven biosciences ApS reported revenue of DKK 6,977,057.
Raven biosciences ApS had 3 employees in 2018 according to the Danish CVR register.
Raven biosciences ApS was founded on 9 November 2017.
Claim this page to add your logo and social links. Free to get started.
Raven biosciences ApS has published its annual report for 2025. Revenue came to DKK 6,977,057, and the net result was DKK 1,065,066.
Raven biosciences ApS has published its annual report for 2024. Revenue came to DKK 5,095,382, and the net result was DKK -925,200.
Raven biosciences ApS has published its annual report for 2023. Revenue came to DKK 7,055,096, and the net result was DKK 429,534.
Raven biosciences ApS has published its annual report for 2022. Revenue came to DKK 12,670,195, and the net result was DKK 2,477,557.
As of December 31, 2022, KGJ Invest ApS is registered as an owner of Raven biosciences ApS with an ownership share of 50%.
As of December 31, 2022, InnoFoss Holding ApS is registered as an owner of Raven biosciences ApS with an ownership share of 50%.
Raven biosciences ApS has published its annual report for 2021. Revenue came to DKK 5,956,861, and the net result was DKK 710,153.
Raven biosciences ApS has published its annual report for 2020. Revenue came to DKK 2,243,527, and the net result was DKK -255,472.
Raven biosciences ApS has published its annual report for 2019. Revenue came to DKK 4,787,235, and the net result was DKK 412,749.
Raven biosciences ApS has published its interim report for the period November 9, 2017 – December 31, 2018.
As of November 9, 2017, Kenneth Graabek Johansen is registered as director of Raven biosciences ApS.
As of November 9, 2017, Roald Forsberg is registered as director of Raven biosciences ApS.
As of November 9, 2017, Kenneth Graabek Johansen is registered as an owner of Raven biosciences ApS with an ownership share of 50%.
As of November 9, 2017, Roald Forsberg is registered as an owner of Raven biosciences ApS with an ownership share of 50%.
Raven biosciences ApS was founded on November 9, 2017.
Companies in the same industry and area
CVR 26539978
CVR 35936858
CVR 25534980
CVR 37845558
CVR 37127663
